[go: up one dir, main page]

IN2014CN04700A - - Google Patents

Info

Publication number
IN2014CN04700A
IN2014CN04700A IN4700CHN2014A IN2014CN04700A IN 2014CN04700 A IN2014CN04700 A IN 2014CN04700A IN 4700CHN2014 A IN4700CHN2014 A IN 4700CHN2014A IN 2014CN04700 A IN2014CN04700 A IN 2014CN04700A
Authority
IN
India
Prior art keywords
chromosome
mutations
ptx
copy
prn
Prior art date
Application number
Other languages
English (en)
Inventor
Chuenchit Boonchird
Wasin Buasri
Watanalai Panbangred
Jean Petre
Original Assignee
Bionet Asia Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49223105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN04700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionet Asia Co Ltd filed Critical Bionet Asia Co Ltd
Publication of IN2014CN04700A publication Critical patent/IN2014CN04700A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN4700CHN2014 2011-12-21 2012-12-20 IN2014CN04700A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201109417 2011-12-21
PCT/TH2012/000052 WO2013141823A1 (en) 2011-12-21 2012-12-20 Modified bordetella pertussis strains

Publications (1)

Publication Number Publication Date
IN2014CN04700A true IN2014CN04700A (fi) 2015-09-18

Family

ID=49223105

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4700CHN2014 IN2014CN04700A (fi) 2011-12-21 2012-12-20

Country Status (9)

Country Link
US (1) US9187754B2 (fi)
EP (1) EP2802646B1 (fi)
JP (1) JP5966018B2 (fi)
KR (1) KR101696986B1 (fi)
CN (1) CN104024400B (fi)
BR (1) BR112014014950B1 (fi)
ES (1) ES2642138T3 (fi)
IN (1) IN2014CN04700A (fi)
WO (1) WO2013141823A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190071706A1 (en) 2016-04-04 2019-03-07 University Of Virginia Patent Foundation Compositions and methods for preventing and treating disease
WO2020011746A1 (en) 2018-07-09 2020-01-16 Dbv Technologies Optimized epicutaneous vaccination
WO2020094580A1 (en) * 2018-11-06 2020-05-14 Glaxosmithkline Biologicals Sa Immunogenic compositions
JP7517002B2 (ja) * 2020-09-10 2024-07-17 トヨタ自動車株式会社 形質転換体の製造方法及び形質転換方法
CA3267059A1 (en) * 2022-09-21 2024-03-28 Prokarium Limited SALMONELLA STRAIN WITH INTEGRATED LANDING PLATFORM AT THE CHROMOSOMAL LEVEL
CN118853525B (zh) * 2024-09-26 2025-01-07 上海羽冠生物技术有限公司 经修饰的百日咳鲍特菌菌株
CN120624499B (zh) * 2025-08-15 2025-11-28 成都生物制品研究所有限责任公司 一种减毒的百日咳鲍特菌重组菌株及其构建方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221618A (en) 1987-11-24 1993-06-22 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8727489D0 (en) 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5358868A (en) 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5244657A (en) 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
EP0396964B1 (en) 1989-04-28 1995-09-06 SCLAVO S.p.A. Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
EP0725653B2 (en) * 1993-10-05 2008-04-02 UCB Pharma Limited Vaccine compositions
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
GB9923060D0 (en) 1999-09-29 1999-12-01 Chiron Spa Vaccine
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents
FI116068B (fi) * 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
WO2005090576A1 (ja) * 2004-03-18 2005-09-29 Japan Health Sciences Foundation 百日咳感染症予防用dna構築物
LT2432884T (lt) 2009-05-22 2016-11-10 Merial, Inc. Neturinti antibiotiko plazmidė

Also Published As

Publication number Publication date
JP5966018B2 (ja) 2016-08-10
US20140302558A1 (en) 2014-10-09
JP2015502758A (ja) 2015-01-29
KR101696986B1 (ko) 2017-01-17
CN104024400A (zh) 2014-09-03
WO2013141823A1 (en) 2013-09-26
BR112014014950B1 (pt) 2022-03-29
KR20140107290A (ko) 2014-09-04
EP2802646A1 (en) 2014-11-19
EP2802646A4 (en) 2015-08-12
EP2802646B1 (en) 2017-05-10
BR112014014950A2 (pt) 2020-06-30
US9187754B2 (en) 2015-11-17
ES2642138T3 (es) 2017-11-15
CN104024400B (zh) 2018-02-16

Similar Documents

Publication Publication Date Title
IN2014CN04700A (fi)
BR112013033366A2 (pt) regulação de genes de toxina e antitoxina para contenção biológica
MX2016009243A (es) Métodos de mutagénesis.
PH12012501746A1 (en) Polynucleotide molecules for gene regulation in plants
CY1117367T1 (el) Αντινοηματικο νουκλεϊνικο οξυ
MX2014012364A (es) Composiciones para controlar acaros varroa en abejas.
UA111193C2 (uk) Застосування n-(тетразол-4-іл)- або n-(триазол-3-іл)арилкарбоксамідів або їх солей для контролю небажаних рослин на площах трансгенних культур, що толерантні до гербіцидів, що є інгібіторами hppd
TW201217533A (en) Genomics of actinoplanes utahensis
Wang et al. IS 5 inserts upstream of the master motility operon flhDC in a quasi-Lamarckian way
MY171760A (en) Microorganisms and methods for the production of caprolactone
IN2014KN01374A (fi)
MY166780A (en) Genetic manipulation and expression system for pucciniomycotina and ustilaginomycotina subphyla
MX369867B (es) Gen y variaciones asociadas con el fenotipo bm1, marcadores moleculares, y su uso.
MX2010002304A (es) Metodos para incorporar multiples genes en una planta de cultivo.
UA115235C2 (uk) Ген токсину axmi335 bacillus thuringiensis та спосіб його застосування
MX2015006958A (es) Autofijacion de nitrogeno en plantas imitando las vias procarioticas.
Kolatka et al. Replication and partitioning of the broad-host-range plasmid RK2
WO2014152607A3 (en) Dosage compensating transgenes and cells
WO2013030176A3 (en) Live attenuated influenza virus
MX2013004044A (es) Composiciones de pared de celula de acido ribonucleico bacterial y metodos para hacerlas y usarlas.
Han et al. Complete genome sequence of carotenoid-producing Microbacterium sp. strain PAMC28756 isolated from an Antarctic lichen
BR112015010138A2 (pt) engenharia bacteriana
IN2014CN03414A (fi)
Oh et al. Complete genome sequence of Hymenobacter sp. strain PAMC26554, an ionizing radiation-resistant bacterium isolated from an Antarctic lichen
CO6761394A2 (es) Microorganismos resistentes a especies reactivas de oxigeno